Nav: Home

Higher BMI not associated with bigger heart attack, death risk in heavier twin

August 04, 2016

A study of monozygotic Swedish twins suggests that while a higher BMI was not associated with increased risk of heart attack or death for the heavier twin, it was associated with increased risk for the onset of diabetes for that twin, according to an article published online by JAMA Internal Medicine.

Monozygotic twins are genetically identical so they provide a unique tool for evaluating risks associated with obesity independent of genetic factors.

Peter Nordström, Ph.D., of the Umeå University, Sweden, and coauthors used a nationwide Swedish twin registry to identify 4,046 monozygotic twin pairs with discordant (differing) body mass indexes (BMIs). The study - conducted from March 1998 to January 2003 with follow-up on outcomes through 2103 - compared the risk of myocardial infarction (MI, heart attack), death and type 2 diabetes in the twin pairs.

During an average follow-up of 12.4 years, there were 203 heart attacks (5 percent) and 550 deaths (13.6 percent) among the heavier twins (average BMI 25.9) compared with 209 heart attacks (5.2 percent) and 633 deaths (15.6 percent) among leaner twins (average BMI 23.9), according to the results. Even in twin pairs where the heavier twin had a BMI of 30 or more, the risk of heart attack or death was not greater in the heavier twin. However, the risk of the onset of diabetes was greater in the heavier twins, the study reports.

Study limitations include self-reported weight and height.

"The present study was not able to verify that obesity is causally associated with an increased risk of MI or death after consideration of genetic factors. In contrast, the results revealed a significant association between obesity and diabetes after accounting for genetic factors. The association between obesity and diabetes was significantly stronger than the association with CVD [cardiovascular disease] and death. This finding may indicate that interventions to promote weight loss are more effective in reducing the risk of diabetes than the risk of CVD and mortality," the study concludes.
-end-
(JAMA Intern Med. Published online August 1, 2016. doi:10.1001/jamainternmed.2016.4104. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Media Advisory: To contact corresponding study author Peter Nordström, Ph.D., email peter.nordstrom@germed.umu.se

The JAMA Network Journals

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
More Diabetes News and Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...